Both the live and archived webcast can be accessed from the Investor Relations page of Savient's Website at http://www.savient.com
. A digital recording of the webcast will be available within one hour following the conclusion of the call and will be available for 14 days. To access the recording, use the dial-in number and the Conference ID listed below.
Dial: 888-203-1112 (domestic) or 719-457-0820 (international)
Conf ID: 5459063
ABOUT SAVIENT PHARMACEUTICALS, INC.
Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and marketing pharmaceutical products that target unmet medical needs in both niche and broader specialty markets. Savient is currently developing one product: KRYSTEXXA(TM) (pegloticase) as a therapy for patients with treatment failure gout, to control hyperuricemia and to manage the signs and symptoms of gout. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA, formerly referred to as Puricase(R), from Duke University and Mountain View Pharmaceuticals, Inc. Savient also manufactures and supplies Oxandrin(R) (oxandrolone tablets, USP) CIII in the U.S. Further information on Savient can be accessed by visiting: http://www.savient.com. Puricase is a registered trademark of Mountain View Pharmaceuticals, Inc.
All statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trend
Page: 1 2 3 4 Related biology technology :1
|SOURCE Savient Pharmaceuticals, Inc.|
Copyright©2009 PR Newswire.
All rights reserved
. Santaris Pharma Director Appointed Adjunct Professor in RNA Biology at the University of Aalborg, Denmark2
. Former GE Healthcare Director, Per Foss Appointed CEO for HUNT Biosciences3
. Paul Keim Appointed to febits Scientific Advisory Board4
. Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics5
. Timothy I. Still Appointed CEO at Accumetrics6
. Robert Cantu Appointed Vice President of Pierpoint International7
. Nader Naeymi-Rad Appointed Chief Operating Officer at Campbell Alliance8
. Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance9
. Dr. Robert N. Butler Appointed to Board of Directors of BioTime, Inc. 10
. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals11
. Lillys Connelly Appointed to the Presidents Commission on White House Fellowships